J05AG Non-nucleoside reverse transcriptase inhibitors
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 14 drugs in this drug class and its subclasses.
- 14 prescription (Rx)
Place in the ATC system
- J Antiinfectives for systemic use 1,101 drugs
- J05 Antivirals for systemic use 246 drugs
- J05A Direct acting antivirals 246 drugs
-
J05AG Non-nucleoside reverse transcriptase inhibitors 14 drugs
- J05AG01 Nevirapine 6 drugs
- J05AG02 Delavirdine 1 drug
- J05AG03 Efavirenz 4 drugs
- J05AG04 Etravirine 1 drug
- J05AG05 Rilpivirine 1 drug
- J05AG06 Doravirine 1 drug
-
J05AG Non-nucleoside reverse transcriptase inhibitors 14 drugs
- J05A Direct acting antivirals 246 drugs
- J05 Antivirals for systemic use 246 drugs
Active ingredients of the class
- Delavirdine mesylate 1 drug
- Doravirine 1 drug
- Efavirenz 4 drugs
- Etravirine 1 drug
- Nevirapine 6 drugs
- Rilpivirine (rilpivirine hydrochloride) 1 drug
Drugs in the class and its subclasses
| Drug | Rx or OTC |
|---|---|
| Apo-Nevirapine PM (J05AG01 Nevirapine) | prescription (Rx) |
| Auro-Nevirapine PM (J05AG01 Nevirapine) | prescription (Rx) |
| Edurant PM (J05AG05 Rilpivirine) | prescription (Rx) |
| Intelence PM (J05AG04 Etravirine) | prescription (Rx) |
| Jamp Nevirapine PM (J05AG01 Nevirapine) | prescription (Rx) |
| Jamp-Efavirenz PM (J05AG03 Efavirenz) | prescription (Rx) |
| Mylan-Efavirenz PM (J05AG03 Efavirenz) | prescription (Rx) |
| Mylan-Nevirapine PM (J05AG01 Nevirapine) | prescription (Rx) |
| Pifeltro PM (J05AG06 Doravirine) | prescription (Rx) |
| Rescriptor PM (J05AG02 Delavirdine) | prescription (Rx) |
| Sustiva 100mg (J05AG03 Efavirenz) | prescription (Rx) |
| Teva-Efavirenz PM (J05AG03 Efavirenz) | prescription (Rx) |
| Teva-Nevirapine PM (J05AG01 Nevirapine) | prescription (Rx) |
| Viramune (J05AG01 Nevirapine) | prescription (Rx) |
Other classes of the same level
- J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 73 drugs
- J05AD Phosphonic acid derivatives, direct acting antivirals 1 drug
- J05AE Protease inhibitors, direct acting antivirals 28 drugs
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 42 drugs
- J05AH Neuraminidase inhibitors, direct acting antivirals 10 drugs
- J05AJ Integrase Inhibitors, antiinfectives for systematic use 9 drugs
- J05AP Antivirals for treatment of HCV infections 16 drugs
- J05AR Antivirals for treatment of HIV infections, combinations 40 drugs
- J05AX Other antivirals 13 drugs
Other names of the drug class
- Czech: J05AG Nenukleosidové inhibitory reverzní transkriptázy
- English (United Kingdom): J05AG Non-nucleoside reverse transcriptase inhibitors
- French: J05AG inhibiteurs de la transcriptase reverse non nucléosidiques
- German: J05AG Nicht-Nukleosidale Inhibitoren der Reversen Transkriptase
- German (Austria): J05AG Nicht-Nukleosidale Inhibitoren der Reversen Transkriptase
- Italian: J05AG NON-NUCLEOSIDI INIBITORI DELLA TRANSCRITTASI INVERSA
- Polish: J05AG Nienukleozydowe inhibitory odwrotnej transkryptazy
- Turkish: J05AG Nükleozid olmayan ters transkriptaz inhibitörleri
- Portuguese (Brazil): J05AG Não-nucleosídeos, inibidores da transcriptase reversa
- German (Switzerland): J05AG Nicht-Nukleosidale Inhibitoren der Reversen Transkriptase
- French (Switzerland): J05AG Inhibiteurs de la transcriptase reverse non nucléosidiques
- Italian (Switzerland): J05AG Non-nucleosidi inibitori della transcrittasi inversa
- Dutch: J05AG Non-nucleoside reverse-transcriptaseremmers
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class J05AG
Ask your doctor or pharmacist for advice.
